Kathryn C. Arbour, MD

Medical Oncologist

Conditions Treated

Memorial Sloan Kettering medical oncologist Kathryn Arbour
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a medical oncologist whose practice is focused on caring for people with lung cancer. I have particular expertise in identifying patients who may benefit from immunotherapy or targeted therapy and incorporating these advanced therapies into their treatment plans. I am also actively involved in clinical trials to find newer and better ways to treat lung cancer.

People with lung cancer are often concerned with how their treatment will impact their day-to-day life. At MSK, our multidisciplinary team of experts is focused on effectively treating our patients’ disease in a way that helps them keep doing the things they love. Using the most advanced therapies in the field, we work together to design treatment plans that minimize side effects to make sure this can happen.

  • Clinical Expertise: Lung Cancer; Targeted Therapy for Lung Cancer; Immunotherapy for Lung Cancer; Clinical Trials
  • Awards and Honors: ASCO Young Investigator Award (2018)
  • Languages Spoken: English
  • Education: MD, Weill Cornell Medical College
  • Residencies: Internal Medicine - NewYork-Presybeterian/Weill Cornell Medical Center; Chief Resident - Memorial Sloan Kettering Cancer Center
  • Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

See My Colleagues


Arbour KC, Jordan E, Kim HR, Dienstag J, Yu HA, Sanchez-Vega F, Lito P, Berger M, Solit DB, Hellmann M, Kris MG, Rudin CM, Ni A, Arcila M, Ladanyi M, Riely GJ. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 Jan 15;24(2):334-340. doi: 10.1158/1078-0432.CCR-17-1841. Epub 2017 Oct 31.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.